Clinical Trial Update: Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of 800 mg Rhodiola Rosea on attention in adults with Attention Deficit Hyperactivity Disorder (ADHD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Rhodiola Rosea

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: UNKNOWN